CN1058535A - Cerebral embolism ablation capsule - Google Patents
Cerebral embolism ablation capsule Download PDFInfo
- Publication number
- CN1058535A CN1058535A CN 90106504 CN90106504A CN1058535A CN 1058535 A CN1058535 A CN 1058535A CN 90106504 CN90106504 CN 90106504 CN 90106504 A CN90106504 A CN 90106504A CN 1058535 A CN1058535 A CN 1058535A
- Authority
- CN
- China
- Prior art keywords
- cerebral
- cerebral embolism
- radix
- present
- ablation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of cerebral embolism ablation capsule, genus prepares medicines.The present invention is based on effecting a permanent cure, by Hirudo, Radix Curcumae, Radix Salviae Miltiorrhizae, Tabanus, Olibanum, Myrrha, pink, the Radix Astragali, Rhizoma Chuanxiong, Fructus Crataegi, Eupolyphaga Seu Steleophaga, Flos Carthami, sodium salicylate adopts the scientific formula of the combination of Chinese and Western medicine to make, and is cerebral thrombosis, cerebral hemorrhage, cerebral arteriosclerosis, the ideal specific drug of cerebral embolism patient.
Description
The present invention relates to a kind of cerebral embolism ablation capsule, genus prepares medicines.
Cerebral thrombosis, cerebral hemorrhage, cerebral arteriosclerosis and cerebral embolism are the diseases that is common in middle-aged and elderly people, can cause patient's hemiplegia, aphasia, sialorrhea, myasthenia of limbs, arrest symptoms such as twin numbness, pain.General medication all can only improve patient's partial symptoms, only takes stopgap measures and can not effect a permanent cure, and the course of treatment is long, and DeGrain and cost are higher.
The objective of the invention is to be based on effecting a permanent cure, a kind of scientific formula of the combination of Chinese and Western medicine is provided, can eliminate patient's misery efficiently after taking at above-mentioned deficiency.
The present invention be achieved in that the present invention by Hirudo, Radix Curcumae, Radix Salviae Miltiorrhizae, Tabanus, Olibanum, Myrrha, pink, the Radix Astragali, Rhizoma Chuanxiong, mountain look into, Eupolyphaga Seu Steleophaga, Flos Carthami, sodium salicylate through mixing, pulverizing, cross 120 mesh sieves, encapsulated making.
The weight ratio of each ingredient of the present invention is respectively:
Hirudo 15～20% Radix Curcumaes 5～10%
Radix Salviae Miltiorrhizae 5～10% Tabanuss 3～8%
Olibanum 10～15% Myrrhas 10～15%
Pink 7～12% Radixs Astragali 10～15%
Rhizoma Chuanxiong 5～10% mountains look into 7～12%
Eupolyphaga Seu Steleophaga 13～18% Flos Carthamis 7～12%
Sodium salicylate 4～9%
The present invention has following advantage: the present invention is once taking, can be rapidly and efficiently the accelerating fibers protein dissolution, promote cerebral thrombosis and blood stasis dissolves and absorbs, softening relax logical cerebrovascular, microcirculation improvement, improve the effective ground eleminating phlegm and freeing channels of cerebral tissue blood supply Qing Kuang And energy, promoting the circulation of QI to relieve pain, thereby reached from the purpose of the fundamentally specific treatment of disease.Because of cheap, taking convenience, the present invention really is the ideal medication of patient again.
253 routine patients are clinical to take the present invention, and the specially good effect rate reaches 92%.For example: patient Deng Xicai, the man, 61 years old, in burst right side upper and lower extremities paralysis on June 13rd, 1, slurred speech, live and be diagnosed as cerebral thrombosis after the packet header dan turns mining area hospital, treat and loseed effect in one month, July 14 was changed to the inventor and punished treatment the same year, take the present invention and can turn walking by post after ten days, cardinal symptom disappears after January, and speech is as usual, and life can be taken care of oneself fully.
The present invention is in use evident in efficacy and do not occur any side effect as yet.
Claims (2)
1, a kind of cerebral embolism ablation capsule is characterized in that the weight ratio of its each ingredient is respectively: Hirudo 15～20%, Radix Curcumae 5～10%, Radix Salviae Miltiorrhizae 5～10%, Tabanus 3～8%, Olibanum 10～15%, Myrrha 10～15%, pink 7～12%, the Radix Astragali 10～15%, Rhizoma Chuanxiong 5～10%, mountain look into 7～12%, Eupolyphaga Seu Steleophaga 13～18%, Flos Carthami 7～12%, sodium salicylate 4～9%.
2, cerebral embolism ablation capsule according to claim 1 is characterized in that it being through mixing, pulverizing, mistake 120 mesh sieves, encapsulated making by each ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 90106504 CN1058535A (en) | 1990-07-27 | 1990-07-27 | Cerebral embolism ablation capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 90106504 CN1058535A (en) | 1990-07-27 | 1990-07-27 | Cerebral embolism ablation capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1058535A true CN1058535A (en) | 1992-02-12 |
Family
ID=4880141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 90106504 Pending CN1058535A (en) | 1990-07-27 | 1990-07-27 | Cerebral embolism ablation capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058535A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056981C (en) * | 1994-11-21 | 2000-10-04 | 于夫 | "Tongmailing" -medicine for promoting blood-circulation and production technology thereof |
| CN1059805C (en) * | 1995-08-07 | 2000-12-27 | 杨旭义 | Capsule for cerebral arteriosclerosis |
| CN1061883C (en) * | 1997-05-07 | 2001-02-14 | 邓庆元 | Medicine for removing thrombus and promoting blood circulation and its preparation |
| CN1074281C (en) * | 1995-12-14 | 2001-11-07 | 北京海尔富药业有限公司 | Chinese medicine prepn |
| CN103830371A (en) * | 2014-03-02 | 2014-06-04 | 卞毓平 | Medicinal preparation for promoting cerebral micro-circulation |
-
1990
- 1990-07-27 CN CN 90106504 patent/CN1058535A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056981C (en) * | 1994-11-21 | 2000-10-04 | 于夫 | "Tongmailing" -medicine for promoting blood-circulation and production technology thereof |
| CN1059805C (en) * | 1995-08-07 | 2000-12-27 | 杨旭义 | Capsule for cerebral arteriosclerosis |
| CN1074281C (en) * | 1995-12-14 | 2001-11-07 | 北京海尔富药业有限公司 | Chinese medicine prepn |
| CN1061883C (en) * | 1997-05-07 | 2001-02-14 | 邓庆元 | Medicine for removing thrombus and promoting blood circulation and its preparation |
| CN103830371A (en) * | 2014-03-02 | 2014-06-04 | 卞毓平 | Medicinal preparation for promoting cerebral micro-circulation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100488549C (en) | Externally applied medicament for treating rheumatism | |
| CN101721664A (en) | Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis | |
| CN1966004A (en) | Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae | |
| CN1079253C (en) | Medicinal oil for dredging channels and collaterals of heart and brain and its preparing process | |
| CN103006951A (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN100358571C (en) | Hot compress plaster for treating mastosis and its preparing method | |
| CN102552517A (en) | Gynecological sugar-free gynaecopathia treating particle and preparation method thereof | |
| CN101129496A (en) | Traditional Chinese medicine for treating intractable headache | |
| CN103463586A (en) | Traditional Chinese medicine composition for treating restless legs syndrome | |
| CN103479929A (en) | Traditional Chinese medicine composition for treating pruritus | |
| CN104873898A (en) | Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia | |
| CN103816476A (en) | Medicine composition for treating injury and paralysis of oculomotor nerve and preparation method and application thereof | |
| CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN1317021C (en) | Chinese medicinal formulation for stopping pain for removing Bi | |
| CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
| CN1058535A (en) | Cerebral embolism ablation capsule | |
| CN101062263A (en) | Medicine for treating coronary heart disease | |
| CN102416145A (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN102327524A (en) | Traditional Chinese medicine composition for curing erysipelas | |
| CN1106279A (en) | Painless bonesetting medicine | |
| CN114732879B (en) | Pharmaceutical composition for gout and uric acid elevation and preparation method and application thereof | |
| CN102349983A (en) | Traditional Chinese medicine composition for treating ischemic apoplexia | |
| CN102018909A (en) | Chinese medicinal preparation for treating ulcer of lower limb | |
| CN101897764A (en) | Chinese medicinal preparation for treating sciatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |